does cjc-1295 build muscle · the honest evidence verdict · research use only
Does CJC-1295 build muscle? The honest answer is: it is not proven in humans.
Short version, before anything else: no published human trial of CJC-1295 has ever measured muscle size, lean body mass, or strength — so the claim 'CJC-1295 builds muscle' is unproven in humans, not established fact. What is actually documented is narrower and more specific. In the key human study, Teichman and colleagues (J Clin Endocrinol Metab 2006;91:799-805) gave single subcutaneous doses of CJC-1295 to healthy adults and reported growth hormone rising roughly 2- to 10-fold and IGF-1 rising about 1.5- to 3-fold; a single dose kept IGF-1 elevated for about 9-11 days, and weekly dosing sustained the IGF-1 rise for around 28 days. But read what that trial measured: hormone levels, pharmacokinetics, and safety — not muscle. There is no CJC-1295 body-composition endpoint in the published human record. Everything you read that says 'CJC-1295 builds muscle' is therefore an extrapolation — from the GH→IGF-1→muscle-protein-synthesis pathway, and from other GH secretagogues that did measure body composition. This page lays out exactly where that inference is solid, where it breaks, and the crucial caveat almost everyone omits: GH-driven 'lean mass' is not the same as contractile muscle or strength. This is a research-use-only reference, not medical, dosing, or human-use advice.
The direct answer: unproven in humans
There is no controlled human trial in which CJC-1295 was given and muscle mass, lean body mass, or strength was measured as an endpoint. The one pivotal human study (Teichman et al., J Clin Endocrinol Metab 2006;91:799-805) measured GH, IGF-1 and safety — not body composition. So the honest verdict is: 'does CJC-1295 build muscle?' has no direct human evidence answering yes. What can be said is that it reliably raises the hormones (GH, IGF-1) that are upstream of muscle-protein synthesis. Elevating those hormones is documented; producing muscle in a healthy person is not.
Best peptides for muscle growth (the honest hub) →What CJC-1295 actually does (the proven part)
CJC-1295 is a long-acting analog of growth hormone-releasing hormone (GHRH). In healthy adults, a single subcutaneous dose raised GH about 2- to 10-fold and IGF-1 about 1.5- to 3-fold, with IGF-1 staying elevated ~9-11 days after one dose and ~28 days on weekly dosing, and an apparent half-life near 6-8 days (Teichman et al., J Clin Endocrinol Metab 2006;91:799-805). That is a genuine, replicated pharmacodynamic result — CJC-1295 does what it is designed to do to GH and IGF-1. It is the bridge everyone uses to argue 'muscle,' but the study itself stops at the hormones.
CJC-1295 + Ipamorelin research guide →Where the 'muscle' idea comes from (the extrapolation)
Because no CJC-1295 human muscle data exists, the muscle rationale is extrapolated from two things. First, the mechanism: GH drives IGF-1, and IGF-1 is a central activator of muscle-protein synthesis via the PI3K-AKT-mTOR pathway (reviewed in Yoshida & Delafontaine, Cells 2020;9:1970; Velloso, Br J Pharmacol 2008;154:557-568). Second, other GH secretagogues that DID measure body composition: capromorelin, an oral GH secretagogue, increased lean body mass by about 1.4 kg vs 0.3 kg on placebo at six months in older adults (White et al., J Clin Endocrinol Metab 2009, doi:10.1210/jc.2008-0632); and MK-677 (ibutamoren) increased fat-free mass by roughly 3 kg vs placebo in a ~2-month RCT in healthy men (reviewed in PMC5632578). These are real results — for other compounds, not for CJC-1295.
MK-677 vs CJC-1295 →The caveat almost everyone skips: lean mass is not strength
Even where GH secretagogues raise 'lean body mass,' that number is not the same as contractile muscle or usable strength. A growth-hormone-replacement RCT in GH-deficient adults (PMID 15126520) increased lean body mass but did NOT significantly improve muscle strength or endurance at 12 months — a large part of GH/IGF-1-driven 'lean mass' can be fluid and non-contractile tissue, not new functional muscle. So even the most favorable read of the secretagogue literature ('raises lean mass') does not license 'builds muscle you can use.' This is the single most important honesty check on any 'CJC-1295 for gains' claim.
Best peptides for recovery →Not a steroid, not a SARM — and the human evidence is the gap
CJC-1295 is a GH secretagogue: it nudges your own pituitary to release GH in pulses. It is not an anabolic steroid, not a SARM, and not FDA-approved for human use. The distinguishing fact for the muscle question is simply the missing evidence: GH and IGF-1 elevation is documented in humans; a muscle-growth or strength outcome from CJC-1295 in healthy adults has never been tested in a controlled trial. Treat any confident 'CJC-1295 builds muscle' claim as marketing that has run ahead of the data. Research-use-only; Titan makes no human-use, dosing, or efficacy claim.
Peptides for focus (research reference) →If you do research it, identity is the real variable
CJC-1295 is a sequence-defined peptide, and the vial Titan stocks is a two-peptide blend (CJC-1295 + Ipamorelin) — so a truncated chain or an off-ratio blend can pass a bare purity number while being the wrong material, in which case none of the research above transfers to that vial. That is why identity by mass spectrometry, matched to the specific lot, matters more than a headline purity percentage. Titan supplies the CJC-1295 + Ipamorelin blend with a lot-matched, in-house release sheet (HPLC purity vs a ≥99% internal target + ESI-MS identity) available on request. No third-party certificate is claimed; the honest edge is a real, lot-matched in-house release sheet.
Lot COA checklist →The detail, in plain terms
Does CJC-1295 build muscle? The evidence, at a glance.
The rows below separate what is proven from what is extrapolated. The documented human finding is GH and IGF-1 elevation — not muscle growth. No controlled human trial has measured muscle or lean body mass after CJC-1295. Treat this as 'raises GH/IGF-1 in studies,' not 'proven to build muscle.' Research use only.
- Direct answer
- Unproven in humans. No published CJC-1295 trial has measured muscle, lean body mass, or strength as an endpoint.
- What IS proven (human)
- Single SC dose raised GH ~2- to 10-fold and IGF-1 ~1.5- to 3-fold (IGF-1 elevated ~9-11 days single dose, ~28 days weekly), half-life ~6-8 days — Teichman et al., J Clin Endocrinol Metab 2006;91:799-805. Hormone data, not muscle data.
- Where 'muscle' comes from
- Extrapolation from (a) the GH→IGF-1→PI3K-AKT-mTOR muscle-protein-synthesis pathway (Yoshida & Delafontaine, Cells 2020;9:1970; Velloso, Br J Pharmacol 2008;154:557-568), and (b) other GH secretagogues that measured body composition.
- Other-secretagogue body-comp data
- Capromorelin: lean body mass +1.4 kg vs +0.3 kg placebo at 6 months (White et al., JCEM 2009, doi:10.1210/jc.2008-0632). MK-677: fat-free mass +~3 kg vs placebo in a ~2-month RCT (reviewed in PMC5632578). Different compounds — not CJC-1295.
- The critical caveat
- 'Lean mass' is not contractile muscle or strength. A GH-replacement RCT (PMID 15126520) raised lean body mass but did NOT significantly improve strength or endurance at 12 months — much of the gain can be fluid/non-contractile.
- What CJC-1295 is NOT
- Not an anabolic steroid, not a SARM, not FDA-approved for human use. Research-use-only compound; no human-use, dosing, or efficacy claim.
- Verdict
- CJC-1295 reliably raises GH/IGF-1 in humans (proven); whether that produces real muscle or strength in healthy trained adults is unproven (no direct human trial).
- Identity check
- Sequence-defined blend; identity by mass spec matched to the lot is the real check, not a bare purity %. Titan: lot-matched in-house HPLC + ESI-MS release sheet on request.
Questions researchers ask
Before you order.
- Does CJC-1295 build muscle?
- Not provably in humans. No published human trial of CJC-1295 has ever measured muscle size, lean body mass, or strength — the pivotal human study (Teichman et al., J Clin Endocrinol Metab 2006;91:799-805) measured growth hormone, IGF-1 and safety only. So 'CJC-1295 builds muscle' is an extrapolation, not a demonstrated result. What is documented is that CJC-1295 reliably raises GH (about 2- to 10-fold) and IGF-1 (about 1.5- to 3-fold) for several days per dose. Raising those hormones is real; producing muscle in a healthy person has not been tested in a controlled trial. This is a research-use-only reference, not medical advice.
- If CJC-1295 raises IGF-1, doesn't that mean it builds muscle?
- It makes muscle growth mechanistically plausible, but plausible is not proven. IGF-1 is a central driver of muscle-protein synthesis via the PI3K-AKT-mTOR pathway (Yoshida & Delafontaine, Cells 2020;9:1970; Velloso, Br J Pharmacol 2008;154:557-568), and CJC-1295 does raise IGF-1 for days after a dose. But no study has taken the next step of showing that this IGF-1 rise translates into measured muscle or strength gains from CJC-1295 in healthy people. The pathway is real; the outcome is untested for this specific peptide. 'Raises IGF-1' and 'builds muscle' are two different claims, and only the first is supported.
- Have any GH secretagogues actually increased muscle in trials?
- Some related compounds increased 'lean body mass' — but not necessarily functional muscle, and none of them are CJC-1295. Capromorelin, an oral GH secretagogue, raised lean body mass by about 1.4 kg vs 0.3 kg on placebo at six months in older adults (White et al., J Clin Endocrinol Metab 2009). MK-677 (ibutamoren) raised fat-free mass by roughly 3 kg vs placebo in a ~2-month RCT (reviewed in PMC5632578). The important caveat: a GH-replacement RCT (PMID 15126520) increased lean body mass but did not significantly improve strength or endurance — much of GH/IGF-1-driven lean mass can be fluid rather than contractile muscle. So even for the compounds that did measure body composition, 'more lean mass' is not the same as 'more usable muscle.'
- Why is CJC-1295 sold with ipamorelin if it doesn't build muscle?
- The pair is a research combination based on two receptors, not a proven muscle-builder. CJC-1295 acts on the GHRH receptor and ipamorelin on the GH-secretagogue (ghrelin) receptor, and co-activating both produces a larger, supra-additive GH pulse than either alone. Ipamorelin is favored because it releases GH without a significant cortisol or prolactin rise. That combination is about maximizing GH release in research models — it is still not a demonstration that the blend increases muscle in humans. Titan stocks the CJC-1295 + Ipamorelin blend as a research-use-only reagent, with no human-use, dosing, or efficacy claim.
- Is CJC-1295 a steroid or a legal way to get 'gains'?
- No. CJC-1295 is a GH secretagogue — it signals your own pituitary to release growth hormone in pulses — not an anabolic steroid and not a SARM. It is not FDA-approved for human use, and it has no controlled-trial evidence for building muscle in healthy people. Marketing that frames it as a legal steroid alternative or a guaranteed way to gain muscle is running past both the regulatory status and the evidence. Titan sells it strictly as a research-use-only compound.
- How do I know a CJC-1295 + Ipamorelin vial is the real material?
- Both are sequence-defined peptides and this SKU is a blend, so a truncated sequence or an off-ratio blend can pass a simple HPLC purity number while being the wrong material — meaning none of the cited research would transfer to that vial. Genuine identity is confirmed by mass spectrometry against the expected sequences, matched to the specific lot, not by purity alone. Titan provides lot-matched, in-house release documentation (HPLC vs a ≥99% internal target + ESI-MS identity) on request. We do not claim a third-party certificate; the verifiable edge is a real, lot-matched in-house release sheet.
Related reading